Radiological evaluation and computed tomography-guided biopsy of pulmonary and mediastinal masses: a prospective study with histopathological correlation
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20261982Keywords:
CT-guided biopsy, Pulmonary mass, Mediastinal mass, Diagnostic accuracyAbstract
Background: Pulmonary and mediastinal masses constitute a significant diagnostic challenge in clinical practice. Computed tomography (CT) is the cornerstone of radiological assessment, while CT-guided biopsy serves as the gold standard for definitive tissue characterization. Objectives of the study was to evaluate CT as an imaging modality and to assess the diagnostic accuracy and safety profile of CT-guided biopsy in pulmonary and mediastinal masses, using histopathology as the reference standard.
Methods: This prospective observational study enrolled 35 patients aged ≥18 years with pulmonary or mediastinal masses referred for CT-guided biopsy at the Department of Radiodiagnosis, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India, from January 2023 to June 2024. CT features including lesion site, margins, enhancement pattern, and associated findings were documented. Tissue samples were correlated with histopathological diagnosis.
Results: Patients were predominantly male (54.3%) and aged above 60 years (60.0%). Pulmonary lesions predominated (91.4%). CT categorized 85.7% of lesions as malignant; histopathology confirmed malignancy in 77.1%, with adenocarcinoma being the most frequent diagnosis (37.1%). The CT–histopathology correlation rate was 88.6%. CT demonstrated sensitivity of 96.3%, specificity of 50.0%, positive predictive value of 86.7%, and negative predictive value of 80.0%. Biopsy adequacy was 94.3%. Complications were limited to mild pneumothorax in 14.3%; no major adverse events occurred.
Conclusion: CT is a highly sensitive modality for evaluating thoracic masses, and CT-guided biopsy is safe with high diagnostic adequacy. The strong radiological–pathological concordance supports an integrated multidisciplinary approach in managing pulmonary and mediastinal masses.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.
Carter BW, Benveniste MF, Madan R, Godoy MC, de Groot PM, Truong MT, et al. ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses. Radiographics. 2017;37(2):413-36.
MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017;284(1):228-43.
Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e93S-120S.
Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC, et al. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010;21(7):969-75.
Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S-65S.
Hiraki T, Mimura H, Gobara H, Iguchi T, Fujiwara H, Sakurai J, et al. CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. Chest. 2009;136(6):1612-7.
Yao X, Gomes MM, Tsao MS, Allen CJ, Geddie W, Sekhon H. Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review. Curr Oncol. 2012;19(1):e16-27.
Manhire A, Charig M, Clelland C, Gleeson F, Miller R, Moss H, et al. Guidelines for radiologically guided lung biopsy. Thorax. 2003;58(11):92036.
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243-60.
Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, et al. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Arch Pathol Lab Med. 2018;142(3):321-46.
Heerink WJ, de Bock GH, de Jonge GJ, Groen HJM, Vliegenthart R, Oudkerk M. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol. 2017;27(1):138-48.
Tomiyama N, Yasuhara Y, Nakajima Y, Adachi S, Arai Y, Kusumoto M, et al. CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol. 2006;59(1):60-4.
Choi SH, Chae EJ, Kim JE, Kim EY, Oh SY, Hwang HJ, et al. Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: analysis of outcomes of 305 procedures from a tertiary referral center. AJR Am J Roentgenol. 2013;201(5):964-70.
Kuniyil J, Sen KK, Mohanty SS, Mitra A, Goyal M, Arora R, et al. Evaluation of lung and mediastinal masses by computed tomography with histopathological correlation. Int J Health Clin Res. 2022;5(1):192-7.
Kaur H, Tiwari P, Dugg P, Ghuman J, Shivhare P, Mehmi RS. Computed tomographic evaluation of mediastinal masses/lesions with contrast enhancement and correlation with pathological diagnosis: a study of 120 cases. J Biomed Graph Comput. 2014;4(3):28.
Tran Anh T, Huynh Quang H, Bui Khac H. Validity of Multi-Slice Computed Tomography in Evaluation of Mediastinal Mass Lesions. Middle East J Cancer. 2022;13(3):515-22.
Piplani S, Mannan R, Lalit M, Manjari M, Bhasin TS, Bawa J. Cytologic-radiologic correlation using transthoracic CT-guided FNA for lung and mediastinal masses: our experience. Anal Cell Pathol (Amst). 2014;2014:343461.
Gadia P, Ukani BV, Singh S, Kotak A, Rathod YR. Evaluation of mediastinal mass lesions using computed tomography and correlation with histopathological diagnosis. Nat J Med Res. 2019;9(01):5-9.
Lee HN, Yun SJ, Kim JI, Ryu CW. Diagnostic outcome and safety of CT-guided core needle biopsy for mediastinal masses: a systematic review and meta-analysis. Eur Radiol. 2020;30(1):588-99.
Ahn JM, Lee KS, Goo JM, Song KS, Kim SJ, Im JG. Predicting the histology of anterior mediastinal masses: comparison of chest radiography and CT. J Thoracic Imaging. 1996;11(4):265-71.
Petranovic M, Gilman MD, Muniappan A, Hasserjian RP, Digumarthy SR, Muse VV, et al. Diagnostic yield of CT-guided percutaneous transthoracic needle biopsy for diagnosis of anterior mediastinal masses. AJR Am J Roentgenol. 2015;205(4):774-9.
Downloads
Published
How to Cite
Issue
Section
